These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Expanded access program for ABT-378 under way. Slovick J Posit Living; 1999 Nov; 8(10):10. PubMed ID: 11367322 [TBL] [Abstract][Full Text] [Related]
14. ICAAC: new drugs in late breaker session. James JS AIDS Treat News; 1999 Oct; (No 328):3-5. PubMed ID: 11366817 [TBL] [Abstract][Full Text] [Related]
15. Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy. Lichterfeld M; Wöhrmann A; Schmeisser N; Fätkenheuer G; Salzberger B; Wyen C; Schmitz K; Sauerbruch T; Rockstroh JK Eur J Med Res; 2003 Feb; 8(2):56-60. PubMed ID: 12626282 [TBL] [Abstract][Full Text] [Related]
16. Predictors of virologic response to ritonavir-boosted protease inhibitors. Marcelin AG; Flandre P; Peytavin G; Calvez V AIDS Rev; 2005; 7(4):225-32. PubMed ID: 16425962 [TBL] [Abstract][Full Text] [Related]
17. Protease inhibitor update. Colvin R; Haas G Common Factor; 1995 Apr; (no 10):15. PubMed ID: 11362340 [TBL] [Abstract][Full Text] [Related]
18. ABT-378 early access program begins. AIDS Treat News; 1999 Oct; (No 328):1-2. PubMed ID: 11366816 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapy. Kempf DJ; Isaacson JD; King MS; Brun SC; Sylte J; Richards B; Bernstein B; Rode R; Sun E Antivir Ther; 2002 Sep; 7(3):165-74. PubMed ID: 12487383 [TBL] [Abstract][Full Text] [Related]
20. Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection. Sahali S; Chaix ML; Delfraissy JF; Ghosn J AIDS Rev; 2008; 10(1):4-14. PubMed ID: 18385776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]